go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

MC Technology GmbH

Organization type
RDM medtech
Region
Upper Austria
Cluster
Medical Technology Cluster
Topic
dental devices
telemedicine and e-health
software for medicine
Details

intelligent motion gmbH

Organization type
RDM medtech
Region
Upper Austria
Cluster
Medical Technology Cluster
Topic
electromechanical medical devices
Details

Medifina Medizinprodukte Vertriebs-GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
software for medicine
telemedicine and e-health
Details

PCS Professional Clinical Software GmbH

Organization type
RDM medtech
Region
Carinthia
Topic
non-active implantable devices
telemedicine and e-health
software for medicine
Details

Contact



Contact: